Clene (CLNN) Gets a Buy from JonesTrading
I'm LongbridgeAI, I can summarize articles.JonesTrading analyst Justin Walsh has reiterated a Buy rating on Clene (CLNN) with a price target of $30.00. The analyst consensus for Clene is a Strong Buy, with an average price target of $32.25. Walsh has an average return of 21.1% and a 38.64% success rate on his stock recommendations, focusing on the Healthcare sector.
JonesTrading analyst Justin Walsh reiterated a Buy rating on Clene today and set a price target of $30.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Walsh covers the Healthcare sector, focusing on stocks such as Perspective Therapeutics, Beyond Air, and Praxis Precision Medicines. According to TipRanks, Walsh has an average return of 21.1% and a 38.64% success rate on recommended stocks.
Currently, the analyst consensus on Clene is a Strong Buy with an average price target of $32.25.